Evnin Anthony B
SEC-identified person · CIK 1239241 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aveo Pharmaceuticals, INC. AVEO | Director | filed 2010–2023 |
| Infinity Pharmaceuticals, INC. INFI | Director | filed 2006–2022 |
| Cantel Medical Corp CMN | Director | filed 2017–2021 |
| Constellation Pharmaceuticals INC CNST | Director | filed 2018–2019 |
| Juno Therapeutics, Inc. JUNO | Director | filed 2014–2018 |
| Acceleron Pharma INC XLRN | Director | filed 2013–2013 |
| Pharmos Corp PARS.PK | Director | filed 2006–2012 |
| Icagen INC ICGN | Director | filed 2007–2011 |
| Viracta Therapeutics, Inc. VIRX | Director | filed 2006–2009 |
| Memory Pharmaceuticals Corp MEMY | Director | filed 2006–2009 |
| Renovis INC RNVS | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.